Human complement component C3 N-glycome changes in type 1 diabetes complications

Changes in N-glycosylation have been described in numerous diseases and are being considered as biomarkers of ongoing pathological condition. Previous studies demonstrated the interrelation of N-glycosylation and type 1 diabetes (T1D), particularly linking serum N-glycan changes with complications a...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Frontiers in endocrinology (Lausanne) Ročník 14; s. 1101154
Hlavní autoři:	Šoić, Dinko, Štambuk, Jerko, Tijardović, Marko, Keser, Toma, Lauc, Gordan, Bulum, Tomislav, Lovrenčić, Marijana Vučić, Rebrina, Sandra Vučković, Tomić, Martina, Novokmet, Mislav, Smirčić-Duvnjak, Lea, Gornik, Olga
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland Frontiers Media S.A 24.05.2023
Témata:	Albuminuria - etiology complement component (C3) Diabetes Mellitus, Type 1 - complications Diabetic Retinopathy - complications Endocrinology Glycopeptides Humans LC-MS Middle Aged N-glycosylation Polysaccharides type 1 diabetes complications LC-MS glycopeptides type 1 diabetes complications complement component (C3) N-glycosylation
ISSN:	1664-2392, 1664-2392
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!